Scleroderma echocardiography or ultrasound: Difference between revisions
Jump to navigation
Jump to search
m Categories |
|||
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Scleroderma}} | {{Scleroderma}} | ||
{{CMG}} | |||
{{CMG}}; {{AE}} {{MKA}} | |||
==Overview== | ==Overview== | ||
There are no [[echocardiography]]/[[ultrasound]] findings directly associated with scleroderma diagnosis. However, a [[Transthoracic echocardiography|transthoracic echocardiography (TTE)]] may be helpful in the diagnosis of complications of scleroderma, which include [[Pulmonary arterial hypertension|pulmonary arterial hypertension (PAH)]]. | |||
==Echocardiography | ==Echocardiography/Ultrasound== | ||
There are no [[echocardiography]]/[[ultrasound]] findings associated with scleroderma. However, a [[Transthoracic echocardiography|transthoracic echocardiography (TTE)]] may be helpful in the diagnosis of complications of scleroderma, which include:<ref name="pmid19389575">{{cite journal |vauthors=McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J |title=ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association |journal=J. Am. Coll. Cardiol. |volume=53 |issue=17 |pages=1573–619 |date=April 2009 |pmid=19389575 |doi=10.1016/j.jacc.2009.01.004 |url=}}</ref><ref name="pmid28270192">{{cite journal |vauthors=Morrisroe K, Stevens W, Sahhar J, Rabusa C, Nikpour M, Proudman S |title=Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme |journal=Arthritis Res. Ther. |volume=19 |issue=1 |pages=42 |date=March 2017 |pmid=28270192 |pmc=5341425 |doi=10.1186/s13075-017-1250-z |url=}}</ref> | |||
*[[Pulmonary arterial hypertension|Pulmonary arterial hypertension (PAH)]] | |||
**For the findings associated with pulmonary arterial hypertension (PAH) on transthoracic echocardiography [[Pulmonary hypertension echocardiography or ultrasound#Echocardiography|click here.]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
{{ | [[Category: (name of the system)]] | ||
{{ | |||
Latest revision as of 13:11, 23 April 2018
|
Scleroderma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scleroderma echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Scleroderma echocardiography or ultrasound |
|
Risk calculators and risk factors for Scleroderma echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
There are no echocardiography/ultrasound findings directly associated with scleroderma diagnosis. However, a transthoracic echocardiography (TTE) may be helpful in the diagnosis of complications of scleroderma, which include pulmonary arterial hypertension (PAH).
Echocardiography/Ultrasound
There are no echocardiography/ultrasound findings associated with scleroderma. However, a transthoracic echocardiography (TTE) may be helpful in the diagnosis of complications of scleroderma, which include:[1][2]
- Pulmonary arterial hypertension (PAH)
- For the findings associated with pulmonary arterial hypertension (PAH) on transthoracic echocardiography click here.
References
- ↑ McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J (April 2009). "ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association". J. Am. Coll. Cardiol. 53 (17): 1573–619. doi:10.1016/j.jacc.2009.01.004. PMID 19389575.
- ↑ Morrisroe K, Stevens W, Sahhar J, Rabusa C, Nikpour M, Proudman S (March 2017). "Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme". Arthritis Res. Ther. 19 (1): 42. doi:10.1186/s13075-017-1250-z. PMC 5341425. PMID 28270192.